Shigenari Nukaga
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Clinical utility of comprehensive genomic profiling versus Oncomine Dx target test in pathological stage II-III non-small cell lung cancer.
Journal: Scientific reports
Published: July 06, 2025
A Case of PMR-Like irAE Developing After Treatment With Ipilimumab and Nivolumab for Lung Cancer.
Journal: Respirology case reports
Published: April 02, 2025
Mutation of CMTR2 in Lung Adenocarcinoma Alters RNA Alternative Splicing and Reveals Therapeutic Vulnerabilities.
Journal: Nature communications
Published: January 27, 2025
Acquisition of FGFR1 and NSD3 Amplifications During the Transformation of EGFR-Mutated Lung Adenocarcinoma into Squamous Cell Carcinoma: A Case Report.
Journal: JTO clinical and research reports
Published: December 18, 2024
Clinical Sequence Revealed the Prevalence and Biological Significance of Somatic Pathogenic Variants in Thoracic Cancer: Implications for Germline Status.
Journal: Clinical lung cancer
Published: November 24, 2024
Diagnostic and prognostic biomarkers for progressive fibrosing interstitial lung disease.
Journal: PloS one
Published: December 21, 2022
Most Important Things and Associated Factors With Prioritizing Daily Life in Patients With Advanced Lung Cancer.
Journal: JCO oncology practice
Published: November 08, 2022
Fusion Genes in Cancer-Toward Treatment from a Pan-Cancer Perspective
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: October 25, 2022
DOCK2 is involved in the host genetics and biology of severe COVID-19.
Journal: Nature
Published: October 26, 2021
Last Updated: 09/26/2026